Wikidata

(Q64184512)

English

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Ad

clinical trial

In more languages

Statements

short name
BREEZE-AD4 (English)
0 references
title
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Austria
0 references
Belgium
0 references
Brazil
0 references
Finland
0 references
France
0 references
Germany
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
15 May 2018
0 references
end time
1 May 2021
0 references
number of participants
500
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64184512&oldid=1857600202"